Skip to main content
Log in

Graves’ disease with neutropenia and marked splenomegaly: autoimmune neutropenia due to propylthiouracil

  • Case Report
  • Published:
Journal of Endocrinological Investigation Aims and scope Submit manuscript

Abstract

A 38-year-old man with Graves’ disease taking propylthiouracil (PTU) for 6 years developed neutropenia and marked splenomegaly. After subtotal thyroidectomy with discontinuance of PTU the patient remained asymptomatic for the last two and half years. The serum obtained during the period of neutropenia demonstrated opsonic activity to neutrophils of the patient as well as of normal volunteers. This opsonic antineutrophil activity was located in the IgG fraction of the serum. Furthermore, PTU at the concentration (0.1–1.0 μg/ml) attainable in the patient’s serum significantly stimulated [3H] thymidine incorporation in the patient’s lymphocytes. These findings indicate that the patient developed autoimmune neutropenia by producing opsonic antineutrophil antibodies in association with the PTU therapy.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Cooper D.S. Antithyroid drugs. N. Engl. J. Med. 311: 1353, 1984.

    Article  PubMed  CAS  Google Scholar 

  2. Wing E.S., Asper S.P. Observations on the use of propylthiouracil in hyperthyroidism with especial reference to long term treatment. Bull. Johns Hopkins Hosp. 90: 201, 1952.

    PubMed  CAS  Google Scholar 

  3. Walzer RA, Einbinder J. Immunoleukopenia as an aspect of hypersensitivity to propylthiouracil. JAMA 184:743, 1963.

    Article  PubMed  CAS  Google Scholar 

  4. Best M.M., Duncan C.H. A lupus-like syndrome following propylthiouracil administration. J.Ky. Med. Assoc. 62: 47, 1964.

    PubMed  CAS  Google Scholar 

  5. Faber V., Elling P. Leukocyte-specific anti-nuclear factors in patients with Felty’s syndrome, rheumatoid arthritis, systemic lupus erythematosus and other diseases. Acta Med. Scand. 179: 257, 1966.

    Article  PubMed  CAS  Google Scholar 

  6. Amrhein J.A., Kenny F.M., Ross D. Granulocytopenia, lupus-like syndrome, and other complications of propylthiouracil therapy. J.Pediatr. 76:54, 1970.

    Article  PubMed  CAS  Google Scholar 

  7. Librik L, Sussman L, Bejar R., Clayton G.W. Thyrotoxicosis and collagen-like disease in three sisters of American indian extraction. J.Pediatr. 76:64, 1970.

    Article  PubMed  CAS  Google Scholar 

  8. Sammon T.J., Peden V.H., Witzleven C., King J.P. Disseminated intravascular coagulation complicating propylthiouracil therapy. A case description of a 16-year old girl. Clin. Pediatr. 70:739, 1971.

    Article  Google Scholar 

  9. Hung W., August G.P. A “collagen-like” syndrome associated with antithyroid therapy. J. Pediatr. 82: 852, 1973.

    Article  PubMed  CAS  Google Scholar 

  10. Vasily D.B., Tyler W.B. Propylthiouracil-induced cutaneous vasculitis. Case presentation and review of the literature. JAMA 243: 458, 1980.

    Article  PubMed  CAS  Google Scholar 

  11. Takuwa N., Kojima I., Ogata E. Lupus-like syndrome — A rare complication in thionam-ide treatment for Graves’ disease. Endocrinol. Jpn. 28: 663, 1981.

    Article  PubMed  CAS  Google Scholar 

  12. Kabashima T. Studies on granulocyte-specific antinuclear factor. Granulocyte-specific antinuclear factor associated with propylthiouracil in patients with hyperthyroidism. Ryumachi 27:22, 1981.

    Google Scholar 

  13. Pacini F., Scridama V., Refetóff S. Multiple complications of propylthiouracil treatment: granulocytopenia, eosinophilia, skin reaction and hepatitis with lymphocyte sensitization. J. Endocrinol. Invest. 5: 403, 1982.

    Article  PubMed  CAS  Google Scholar 

  14. Berkman E.M., Orlin J.B., Wolfsdorf J. An anti-neutrophil antibody associated with a propylthiouracil-induced lupus-like syndrome. Transfusion 23: 135, 1983.

    Article  PubMed  CAS  Google Scholar 

  15. Weinstein A. Drug-induced systemic lupus erythematosus. In: Schwartz R.S. (Ed.), Progress in Clinical Immunology. Grune & Stratton, New York, vol. 4, 1980, p. 1.

    PubMed  CAS  Google Scholar 

  16. DeGroot L.J., Stanbury J.B. The thyroid and its disorders, ed. 4. Jon Willy & Sons, New York, 1975, p. 288.

    Google Scholar 

  17. Boxer L.A., Greenberg M.S., Boxer G.J., Stossel T.P. Autoimmune neutropenia. N Engl. J. Med. 293: 748, 1975.

    Article  PubMed  CAS  Google Scholar 

  18. Weitzman S.A., Stossel T.P., Desmuond M. Drug-induced immunological neutropenia. Lancet?: 1: 1068, 1978.

    Article  PubMed  CAS  Google Scholar 

  19. Boxer LA, Stossel T.P. Effects of anti-human neutrophil antibodies in vitro. quantitative studies. J. Clin. Invest. 53:1534, 1974.

    Article  PubMed Central  PubMed  CAS  Google Scholar 

  20. Shishiba Y., Ozawa Y., Ohtsuki N., Shimizu T. Discrepancy between thyroid-stimulating and thyrotropin-binding inhibitory activities of Graves’ Immunoglob ulin Gs assessed in the mouse. J. Clin. Endocrinol. Metab. 54: 858, 1982.

    Article  PubMed  CAS  Google Scholar 

  21. Waithe W.I., Hirschhom K. Lymphocyte response to activators. In: Weir D.M. (Ed.), Handbook of experimental immunology, ed. 3. Blackwell Publisher, 1978, vol. 2, Chapt. 26:1.

    Google Scholar 

  22. Sato K., Mimura H., Kato S., Isozaki O., Tsushima T., Shizume K. Serum propylthiouracil concentration in patients with Graves’ disease with various clinical course. Acta Endocrinol. 104: 189, 1983.

    PubMed  CAS  Google Scholar 

  23. Woosley R.L., Drayer D.E., Reidenberg M.M., Nies A.S., Carr K., Oates J.A. Effect of acetylator phenotype on the rate at which procainamide induces antinuclear antibodies and the lupus syndrome. N.Engl. J. Med. 298:1157, 1978.

    Article  PubMed  CAS  Google Scholar 

  24. Marchant B., Less J.F.H., Alexander W.D. Antithyroid drugs. Pharmacol. Ther. 3: 305, 1978.

    CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Sato, K., Miyakawa, M., Han, D.C. et al. Graves’ disease with neutropenia and marked splenomegaly: autoimmune neutropenia due to propylthiouracil. J Endocrinol Invest 8, 551–555 (1985). https://doi.org/10.1007/BF03348560

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03348560

Key-words

Navigation